Petrus Jong serves as the Head of Translational Medicine and Early Clinical Development at Endeavor Biomedicines, where he leverages over 15 years of expertise in oncology, inflammation/immunology, and rare diseases. His extensive background in both academia and the pharmaceutical industry positions him as a leader...
Petrus Jong serves as the Head of Translational Medicine and Early Clinical Development at Endeavor Biomedicines, where he leverages over 15 years of expertise in oncology, inflammation/immunology, and rare diseases. His extensive background in both academia and the pharmaceutical industry positions him as a leader in the field of translational medicine, where he is instrumental in bridging the gap between laboratory research and clinical application. Currently, Petrus is the Medical and Translational Lead for ENV-501, a HER3-targeted antibody-drug conjugate (ADC) designed to enhance therapeutic outcomes in cancer treatment.
In this pivotal role, Petrus spearheads the clinical development strategy, ensuring that the transition from preclinical studies to early-phase clinical trials is seamless and scientifically robust. His responsibilities encompass authoring critical clinical and regulatory documents, overseeing medical monitoring, and conducting thorough patient safety reviews. Petrus is also adept at establishing clinical advisory boards and developing patient selection strategies that optimize trial design and enhance the likelihood of successful outcomes.
His technical skills in cell culture, immunology, and animal models complement his strategic leadership, allowing him to effectively manage cross-functional teams and drive innovative research initiatives. With a strong emphasis on collaboration and communication, Petrus fosters an environment where scientific inquiry thrives, ultimately aiming to bring transformative therapies to patients with unmet medical needs. His commitment to advancing translational medicine not only reflects his passion for medical research but also underscores his dedication to improving patient lives through cutting-edge therapeutic solutions.
